Skip to content

Exploring the Therapeutic Effects of Potential Targets for Transcranial Electrical Stimulation in Patients with Neurodevelopmental Disorders: A Randomized Double-Blind Sham-Controlled Clinical Trial

Exploring the Therapeutic Effects of Potential Targets for Transcranial Electrical Stimulation in Patients with Neurodevelopmental Disorders: A Randomized Double-Blind Sham-Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107848
Enrollment
Unknown
Registered
2025-08-20
Start date
2025-09-20
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

ASD-TI / IF-True Stimulation Group:temporal interference stimulation / Interferential Stimulation-True Stimulation
ASD-TI/IF-Sham Stimulation Group:temporal interference stimulation / Interferential Stimulation-Sham Stimulation
ADHD-tACS-True Stimulation Group:Transcranial alternating current stimulation-True Stimulation
ADHD-tACS-Sham Stimulation Group:Transcranial alternating current stimulation-Sham Stimulation
DD-tDCS True stimulation group:Transcranial direct current stimulation-True stimulation
DD-tDCS Shan stimulation group:Transcranial direct current stimulation-Sham stimulation

Sponsors

The Affiliated Brain Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 16 Years

Inclusion criteria

Inclusion criteria: (1) Age between 4 and 16 years; (2) IQ greater than 70; (3) Diagnosis meets the criteria for Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, or Tic Disorders as per DSM-5; (4) No pharmacological treatment received in the 2 weeks prior to enrollment (may be relaxed to 3 days), and no standardized non-pharmacological interventions have been administered; (5) Right-handedness.

Exclusion criteria

Exclusion criteria: (1) Comorbid with other mental disorders as defined in the DSM-5; (2) presence of suicidal ideation or plans; (3) concurrent severe physical illness; (4) history of epileptic seizures; (5) received modified electroconvulsive therapy (MECT), repetitive transcranial magnetic stimulation (rTMS), or transcranial electrical stimulation (tES) within the past three months; (6) presence of metallic implants in the body, such as cochlear implants, cardiac pacemakers, or intracranial metallic implants; (7) hypersensitivity, injury, or inflammation in the stimulation area; (8) contraindications for MRI scanning, such as claustrophobia.

Design outcomes

Primary

MeasureTime frame
Language ability;Social competence;Severity of autism symptoms;Level of Brain Activity;Brain wave patterns;

Secondary

MeasureTime frame
Irritable mood issues;Sleep Quality;

Countries

China

Contacts

Public ContactXiaoyan Ke

The Affiliated Brain Hospital of Nanjing Medical University

wangyonglu@stu.njmu.edu.cn+86 133 0517 6562

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026